Ignite Creation Date:
2024-05-06 @ 6:06 PM
Last Modification Date:
2024-10-26 @ 2:41 PM
Study NCT ID:
NCT05549661
Status:
RECRUITING
Last Update Posted:
2024-06-21
First Post:
2022-09-19
Brief Title:
Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia
Sponsor:
Organization:
Mayo Clinic